Yury I. Miller
- Immunology top 0.5%
- Atherosclerosis and Cardiovascular Diseases 39
- Immune Response and Inflammation 13
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 10
- Immune cells in cancer 9
- Biochemistry top 0.5%
- Antioxidant Activity and Oxidative Stress 12
- Immunology and Allergy top 1%
- Cancer Research top 2%
- Cell Biology top 1%
-
- Cholesterol and Lipid Metabolism 16
-
- Peroxisome Proliferator-Activated Receptors 15
-
- Adipokines, Inflammation, and Metabolic Diseases 9
- Co-authors
- Joseph L. WitztumChristoph J. BinderLonghou FangKarsten HartvigsenSotirios TsimikasFelicidad AlmazanNurith ShaklaiPeter X. Shaw
- Partner nations
- United StatesSouth KoreaAustralia
In The Last Decade
Yury I. Miller
98 papers receiving 8.3k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Immunology 4.2k
- Biochemistry 550
- Immunology and Allergy 382
- Cancer Research 727
- Cell Biology 781
Countries citing papers authored by Yury I. Miller
This map shows the geographic impact of Yury I. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yury I. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yury I. Miller more than expected).
Fields of papers citing papers by Yury I. Miller
This network shows the impact of papers produced by Yury I. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yury I. Miller. The network helps show where Yury I. Miller may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yury I. Miller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 10 | |
| 5 | 2020 | 16 | |
| 6 | 2019 | 95 | |
| 7 | 2018 | 41 | |
| 8 | 2018 | 26 | |
| 9 | 2018 | 20 | |
| 10 | 2018 | 60 | |
| 11 | 2018 | 38 | |
| 12 | 2015 | 18 | |
| 13 | 2013 | 1 | |
| 14 | 2012 | 197 | |
| 15 | 2012 | 123 | |
| 16 | 2009 | 212 | |
| 17 | 2006 | 54 | |
| 18 | 2003 | 139 | |
| 19 | 2003 | 58 | |
| 20 | 1999 | 123 |
About Yury I. Miller
Yury I. Miller is a scholar working on Immunology, Biochemistry and Immunology and Allergy, having authored 102 papers that have together received 8.4k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (39 papers), Cholesterol and Lipid Metabolism (16 papers), Peroxisome Proliferator-Activated Receptors (15 papers), Immune Response and Inflammation (13 papers), Antioxidant Activity and Oxidative Stress (12 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (10 papers), Adipokines, Inflammation, and Metabolic Diseases (9 papers) and Immune cells in cancer (9 papers). The work is most often cited by research in Immunology (4.2k citations), Biochemistry (550 citations) and Immunology and Allergy (382 citations). Yury I. Miller has collaborated with scholars based in United States, South Korea and Australia. Frequent co-authors include Joseph L. Witztum, Christoph J. Binder, Longhou Fang, Karsten Hartvigsen, Sotirios Tsimikas, Felicidad Almazan, Nurith Shaklai, Peter X. Shaw, Klaus Ley and Mi-Kyung Chang. Their work appears in journals such as Nature, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.